Home > Qtrly Results > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Quarterly Results Analysis [Jun2026]

TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Quarterly Results

Consolidated Jun2026
UnAudited
Mar2026
UnAudited
Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Revenues ₹4,921 Cr ₹4,197 Cr ₹3,303 Cr ₹3,302 Cr ₹3,178 Cr ₹2,959 Cr ₹2,809 Cr ₹2,889 Cr
Expenses ₹3,257 Cr ₹2,841 Cr ₹2,215 Cr ₹2,219 Cr ₹2,146 Cr ₹1,995 Cr ₹1,895 Cr ₹1,950 Cr
Operating Income ₹1,664 Cr ₹1,356 Cr ₹1,088 Cr ₹1,083 Cr ₹1,032 Cr ₹964 Cr ₹914 Cr ₹939 Cr
Other Income ₹-12 Cr ₹-17 Cr ₹-13 Cr ₹-27 Cr ₹-37 Cr ₹-18 Cr ₹33 Cr ₹-16 Cr
Interest ₹305 Cr ₹236 Cr ₹45 Cr ₹48 Cr ₹56 Cr ₹56 Cr ₹57 Cr ₹64 Cr
Depreciation ₹593 Cr ₹508 Cr ₹206 Cr ₹204 Cr ₹201 Cr ₹201 Cr ₹199 Cr ₹198 Cr
Profit Before Tax ₹733 Cr ₹529 Cr ₹814 Cr ₹791 Cr ₹738 Cr ₹665 Cr ₹691 Cr ₹661 Cr
Profit After Tax ₹566 Cr ₹364 Cr ₹635 Cr ₹591 Cr ₹548 Cr ₹498 Cr ₹503 Cr ₹453 Cr
EPS ₹16.72 ₹11.49 ₹18.76 ₹17.46 ₹16.19 ₹14.71 ₹14.86 ₹13.38
Industry Peers & Returns1W1M1Y
TORRENT PHARMACEUTICALS 1.7% -0.6% 35.5%
SUN PHARMACEUTICAL INDUSTRIES -3% -4.1% 16.7%
DIVIS LABORATORIES 0.6% 17.5% 41.9%
CIPLA -2% -0.7% -4.9%
DR REDDYS LABORATORIES -1.5% -3.5% -2.2%
MANKIND PHARMA -1.4% -6.9% -1.5%
LUPIN -1.8% -10.2% 16.1%
ZYDUS LIFESCIENCES -7.2% -2.6% 18.5%
AUROBINDO PHARMA -1.6% 5% 54.4%

TORRENT PHARMACEUTICALS Quarterly Revenues

Revenues
Q-o-Q

17.25 %

Y-o-Y

54.85 %

Quarters Revenues % Change
Jun2026 ₹4,921 Cr
17.25
Mar2026 ₹4,197 Cr
27.07
Dec2025 ₹3,303 Cr
0.03
Sep2025 ₹3,302 Cr
3.90
Jun2025 ₹3,178 Cr
7.40
Mar2025 ₹2,959 Cr
5.34
Dec2024 ₹2,809 Cr
-2.77
Sep2024 ₹2,889 Cr -

TORRENT PHARMACEUTICALS Quarterly Operating Profit

Operating Profit
Q-o-Q

22.71 %

Y-o-Y

61.24 %

Quarters Operating Profit % Change
Jun2026 ₹1,664 Cr
22.71
Mar2026 ₹1,356 Cr
24.63
Dec2025 ₹1,088 Cr
0.46
Sep2025 ₹1,083 Cr
4.94
Jun2025 ₹1,032 Cr
7.05
Mar2025 ₹964 Cr
5.47
Dec2024 ₹914 Cr
-2.66
Sep2024 ₹939 Cr -
Operating Margins
Q-o-Q

4.64 %

Y-o-Y

4.13 %

Quarters Operating Margin% % Change
Jun2026 33.81%
4.64
Mar2026 32.31%
-1.91
Dec2025 32.94%
0.43
Sep2025 32.8%
1.02
Jun2025 32.47%
-0.34
Mar2025 32.58%
0.12
Dec2024 32.54%
0.12
Sep2024 32.5% -

TORRENT PHARMACEUTICALS Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

55.49 %

Y-o-Y

3.28 %

Quarters Profit After Tax % Change
Jun2026 ₹566 Cr
55.49
Mar2026 ₹364 Cr
-42.68
Dec2025 ₹635 Cr
7.45
Sep2025 ₹591 Cr
7.85
Jun2025 ₹548 Cr
10.04
Mar2025 ₹498 Cr
-0.99
Dec2024 ₹503 Cr
11.04
Sep2024 ₹453 Cr -
PAT Margins
Q-o-Q

32.64 %

Y-o-Y

-33.29 %

Quarters PAT Margin(%) % Change
Jun2026 11.5 %
32.64
Mar2026 8.67 %
-54.89
Dec2025 19.22 %
7.37
Sep2025 17.9 %
3.83
Jun2025 17.24 %
2.44
Mar2025 16.83 %
-6.03
Dec2024 17.91 %
14.22
Sep2024 15.68 % -

TORRENT PHARMACEUTICALS Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

45.52 %

Y-o-Y

3.27 %

Quarters EPS % Change
Jun2026 ₹16.72
45.52
Mar2026 ₹11.49
-38.75
Dec2025 ₹18.76
7.45
Sep2025 ₹17.46
7.84
Jun2025 ₹16.19
10.06
Mar2025 ₹14.71
-1.01
Dec2024 ₹14.86
11.06
Sep2024 ₹13.38 -

You may also like the below Video Courses